α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

Ferlay, 2004

El-Serag, 2004, Hepatocellular carcinoma: recent trends in the United States, Gastroenterology, 127, S27, 10.1053/j.gastro.2004.09.013

Parkin, 2006, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, 118, 3030, 10.1002/ijc.21731

Bruix, 2005, Management of hepatocellular carcinoma, Hepatology, 42, 1208, 10.1002/hep.20933

El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001

El-Serag, 2008, Diagnosis and treatment of hepatocellular carcinoma, Gastroenterology, 134, 1752, 10.1053/j.gastro.2008.02.090

Fattovich, 2004, Hepatocellular carcinoma in cirrhosis: incidence and risk factors, Gastroenterology, 127, S35, 10.1053/j.gastro.2004.09.014

Marrero, 2005, Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass, Liver Transpl, 11, 281, 10.1002/lt.20357

Pepe, 2001, Phases of biomarker development for early detection of cancer, J Natl Cancer Inst, 93, 1054, 10.1093/jnci/93.14.1054

Colli, 2006, Alpha-fetoprotein and hepatocellular carcinoma, Am J Gastroenterol, 101, 1939, 10.1111/j.1572-0241.2006.00684_3.x

Gupta, 2003, Test characteristics of α-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C, Ann Intern Med, 139, 46, 10.7326/0003-4819-139-1-200307010-00012

Gebo, 2002, Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review, Hepatology, 36, S84

Ono, 1990, Measurement of immunoreactive prothrombin precursor and vitamin-K-dependent γ-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-γ-carboxyprothrombin synthesis, Tumour Biol, 11, 319, 10.1159/000217667

Shimauchi, 2000, A simultaneous monitoring of Lens culinaris agglutinin A-reactive α-fetoprotein and des-γ-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients, Oncol Rep, 7, 249

Marrero, 2003, Des-γ carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients, Hepatology, 37, 1114, 10.1053/jhep.2003.50195

Ikoma, 2002, Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-γ-carboxy prothrombin: a prospective study, Hepatogastroenterology, 49, 235

Ishii, 2000, Simultaneous measurements of serum α-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma, Am J Gastroenterol, 95, 1036

Sato, 1993, Early recognition of hepatocellular carcinoma based on altered profiles of α-fetoprotein, N Engl J Med, 328, 1802, 10.1056/NEJM199306243282502

Shiraki, 1995, A clinical study of lectin-reactive α-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients, Hepatology, 22, 802, 10.1002/hep.1840220317

Wang, 1996, Utility of lentil lectin affinity of α-fetoprotein in the diagnosis of hepatocellular carcinoma, J Hepatol, 25, 166, 10.1016/S0168-8278(96)80069-9

Sterling, 2007, Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis, Am J Gastroenterol, 102, 2196, 10.1111/j.1572-0241.2007.01405.x

Bruix, 2001, Clinical management of hepatocellular carcinoma, J Hepatol, 35, 421, 10.1016/S0168-8278(01)00130-1

Trevisani, 2001, Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status, J Hepatol, 34, 570, 10.1016/S0168-8278(00)00053-2

Marrero, 2005, Screening tests for hepatocellular carcinoma, Clin Liver Dis, 9, 235, 10.1016/j.cld.2004.12.006

Volk, 2008, Early detection of liver cancer: diagnosis and management, Curr Gastroenterol Rep, 10, 60, 10.1007/s11894-008-0010-2